Bright Minds Biosciences Stock Total Asset
| DRUG Stock | USD 34.03 1.91 5.31% |
Bright Minds Biosciences fundamentals help investors to digest information that contributes to Bright Minds' financial success or failures. It also enables traders to predict the movement of Bright Stock. The fundamental analysis module provides a way to measure Bright Minds' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bright Minds stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 7 M | 8.5 M |
Bright | Total Asset |
Bright Minds Biosciences Company Total Asset Analysis
Bright Minds' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Bright Minds Total Asset | 6.1 M |
Most of Bright Minds' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bright Minds Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bright Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Bright Minds is extremely important. It helps to project a fair market value of Bright Stock properly, considering its historical fundamentals such as Total Asset. Since Bright Minds' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bright Minds' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bright Minds' interrelated accounts and indicators.
Click cells to compare fundamentals
Bright Total Asset Historical Pattern
Today, most investors in Bright Minds Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bright Minds' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bright Minds total asset as a starting point in their analysis.
Bright Minds Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Bright Total Assets
Total Assets |
|
Based on the latest financial disclosure, Bright Minds Biosciences has a Total Asset of 6.1 M. This is 99.92% lower than that of the Biotechnology sector and 99.69% lower than that of the Health Care industry. The total asset for all United States stocks is 99.98% higher than that of the company.
Bright Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bright Minds' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bright Minds could also be used in its relative valuation, which is a method of valuing Bright Minds by comparing valuation metrics of similar companies.Bright Minds is currently under evaluation in total asset category among its peers.
Bright Minds ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bright Minds' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bright Minds' managers, analysts, and investors.Environmental | Governance | Social |
Bright Minds Institutional Holders
Institutional Holdings refers to the ownership stake in Bright Minds that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bright Minds' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bright Minds' value.| Shares | Adage Capital Partners Gp Llc | 2024-12-31 | 132.5 K | Walleye Trading Advisors, Llc | 2024-12-31 | 103.2 K | Schonfeld Strategic Advisors Llc | 2024-12-31 | 69.8 K | Longwood Capital Partners Llc | 2024-12-31 | 69.1 K | Millennium Management Llc | 2024-12-31 | 40.4 K | Atika Capital Management Llc | 2024-12-31 | 15 K | Ubs Group Ag | 2024-12-31 | 10.2 K | Jane Street Group Llc | 2024-12-31 | 6.6 K | Bank Of America Corp | 2024-12-31 | 4.8 K | Cormorant Asset Management, Llc | 2024-12-31 | 1.1 M | Hhg Plc | 2024-12-31 | 508.8 K |
Bright Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 213.24 M | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 27.28 % | ||||
| Shares Owned By Institutions | 44.27 % | ||||
| Number Of Shares Shorted | 137.7 K | ||||
| Price To Book | 6.08 X | ||||
| EBITDA | (7.28 M) | ||||
| Net Income | (2.8 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 118.96 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (1.85 M) | ||||
| Short Ratio | 1.24 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 92.32 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 226.37 M | ||||
| Total Asset | 6.1 M | ||||
| Retained Earnings | (34.35 M) | ||||
| Working Capital | 5.46 M | ||||
| Net Asset | 6.1 M |
About Bright Minds Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bright Minds Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bright Minds using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bright Minds Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Bright Minds Piotroski F Score and Bright Minds Altman Z Score analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.